<DOC>
	<DOCNO>NCT01690221</DOCNO>
	<brief_summary>The purpose study determine study drug , VEN307 ( diltiazem hydrochloride cream ) safe see help treatment pain associate anal fissure .</brief_summary>
	<brief_title>Efficacy Safety Study With Diltiazem Hydrochloride Cream Treat Anal Fissures</brief_title>
	<detailed_description>Primary Objective : To evaluate efficacy diltiazem hydrochloride cream reduction bad anal fissure ( AF ) -related pain associate follow defecation administer three time day ( TID ) 28 day .</detailed_description>
	<mesh_term>Fissure Ano</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<criteria>1 . Males female , age ≥ 18 ≤ 75 year . 2 . Subjects evidence circumscribe fissure , induration edge . 3 . Subjects AFrelated pain associate follow defecation occur least 2 time week least 28 day prior sign inform consent form ( ICF ) . 4 . AFrelated pain associate follow defecation least 5 11point numerical rating score scale ( NRS ) last defecation prior sign ICF ( 0 pain ; 10 bad possible pain ) . 5 . Average AFrelated pain associate follow defecation least 5 11point NRS last 3 day subject defecation 7 day prior randomization . 6 . Any female nonchildbearing potential , include female : ) hysterectomy , b ) bilateral oophorectomy , c ) bilateral tubal ligation ) post menopausal ( demonstration total cessation menses ≥ 1 year date screen visit ) . 7 . Females child bear potential agree use least one form contraception ( may barrier method ) , full duration study . 8 . Able communicate adequately investigator comply requirement entire study . 9 . Capable use IVRS able adequately communicate comprehension IVRS question investigator . 10 . Capable freely willing provide write informed consent prior participate study . 1 . Unwilling visual medical examination AF . 2 . More 1 AF . 3 . Subjects AF associate caused condition , include limited : druginduced , trauma , HIV infection , fistulainano , inflammatory bowel disease , perianal sepsis malignancy . 4 . Unwilling stop concomitant topical preparation apply around anus sign ICF Day 29 study . 5 . Use glyceryl trinitrate ( GTN ) ointment 7 day ( continuous ) 28 day prior sign ICF . 6 . Unwilling discontinue use sitz bath 4 hour application investigational product signing ICF end study . 7 . Unwilling discontinue use anesthetic sign ICF end study . 8 . Subfissure injection botulinum toxin 3 month prior sign ICF . 9 . Known sensitivity investigational product ( ) calcium channel blocker . 10 . Previous treatment diltiazem hydrochloride cream topical calcium channel blocker . 11 . Active treatment antiviral therapy HIV ( e.g . indinavir , nelfinivir , ritonavir ) . 12 . Treatment follow medication within 14 day prior sign ICF : Amitriptyline Benzodiazepines βadrenoceptor antagonist ( BetaBlockers ) Buspirone Calcium channel blocker Carbamazepine Cimetidine Cyclosporin Digoxin Investigational agent Lovastatin Opioids Pregabalin Quinidine Rifampin 13 . Following concomitant disease state : Sick sinus syndrome except presence function ventricular pacemaker . Secondor thirddegree AV block except presence function ventricular pacemaker . Hypotension ( less 90 mm Hg systolic ) . Acute myocardial infarction pulmonary congestion document xray . History bipolar disorder , psychosis , schizophrenia , mania , suicide attempt suicidal ideation , significant psychiatric illness ( exception intermittent anxiety ) per investigator judgment . History clinically significant renal disease per investigator judgment . History clinically significant Alzheimer 's Parkinson 's disease per investigator judgment . History clinically significant hepatic disease per investigator judgment . Current infection treat macrolide antibiotic . Clinical evidence history fecal incontinence . Clinical evidence history anal fistula . Clinical evidence history anal abscess . History inflammatory bowel disease ( e.g . Crohn 's disease , Ulcerative Colitis ) . History prior anal rectal surgery include limited : lateral sphincterotomy anal stretch ( exception hemorrhoidal band laser surgery ) . Grade 4 hemorrhoid . Chronic constipation . 14 . History radiation therapy pelvis . 15 . Fixed anal stenosis/fibrosis . 16 . Major organ transplant . 17 . Any clinically significant laboratory abnormality screen per investigator judgment . 18 . Body Mass Index ( BMI ) &gt; 40 kg/m2 19 . Malignancy within 5 year prior randomization ( exception treat basal cell/squamous cell carcinoma skin ) . 20 . Any disease prior/planned surgery may interfere subject successfully complete study . 21 . Currently use narcotic ( ) . 22 . Breastfeeding female . 23 . Employees , family member , student investigator clinical site .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Anal</keyword>
	<keyword>Fissure</keyword>
	<keyword>Pain</keyword>
</DOC>